Literature DB >> 9866157

[Association of allele polymorphism of dopamine d2 receptors with schizophrenic and affective disorders].

V E Golimbet, M G Aksenova, L I Abramova, V G Kaleda, V A Orlova, E A Braga, V V Nosikov, V I Trubnikov.   

Abstract

DRD2 Taq polymorphism has been studied in the samples from 214 patients (119 males, 95 females, mean age 37.8 +/- 13.6) and of 96 controls (50 males, 46 females, mean age 40.7 +/- 20.0). The latter group comprised 75 unrelated controls and 21 healthy first degree relatives of schizophrenic patients. All the patients were diagnosed according to ICD-10 and have been divided into 4 groups: paranoid schizophrenics (n = 102), schizotypic patients (n = 25), patients with schizoaffective psychoses (n = 40) and affective disorders (n = 47). Taq1A DRD2 polymorphism was represented by 3 genotypes: A1A1, A1A2, A2A2 (allele A2 was a result of nucleotide substitution). The frequencies of genotypes in affected group didn't significantly differ from a control one. However, a frequency of A2A2 genotype (0.45) in a group of paranoid schizophrenics was significantly higher, than in the patients with schizoaffective psychoses (0.22) or in a control group (0.26), but was similar to that of the patients with schizotypic or affective disorders (0.4). A2A2 DRD2 genotype seems to be a potential genetic factor of susceptibility to schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9866157

Source DB:  PubMed          Journal:  Zh Nevrol Psikhiatr Im S S Korsakova        ISSN: 1997-7298


  4 in total

1.  Analysis of the linkage of the Taq1A and Taq1B loci of the dopamine D2 receptor gene with schizophrenia in patients and their siblings.

Authors:  V E Golimbet; M G Aksenova; V V Nosikov; V A Orlova; V G Kaleda
Journal:  Neurosci Behav Physiol       Date:  2003-03

Review 2.  Genetic polymorphisms in the expression and treatment of neuropsychiatric disorders.

Authors:  Thomas W McAllister; Lanier Summerall
Journal:  Curr Psychiatry Rep       Date:  2003-10       Impact factor: 5.285

3.  The ANKK1 kinase gene and psychiatric disorders.

Authors:  Guillermo Ponce; Rocío Pérez-González; María Aragüés; Tomás Palomo; Roberto Rodríguez-Jiménez; Miguel Angel Jiménez-Arriero; Janet Hoenicka
Journal:  Neurotox Res       Date:  2009-04-07       Impact factor: 3.911

4.  Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a South Indian population.

Authors:  Neetha N Vijayan; Sujatha Bhaskaran; Linda V Koshy; Chandrasekhar Natarajan; Lekshmy Srinivas; Chandrasekharan M Nair; Priya M Allencherry; Moinak Banerjee
Journal:  Behav Brain Funct       Date:  2007-07-25       Impact factor: 3.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.